Eko Health received FDA clearance this week for a new AI-powered tool that aids in the early detection of low ejection fraction, a key indicator of heart failure. About 6.2 million Americans battle ...

August 12, 2011 — Older patients are more likely than younger patients with a similar low left ventricular ejection fraction to have cognitive decline, report researchers. "Cognitive dysfunction due ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leading artificial intelligence (AI)-driven health technology company, announced that the Centers for Medicare & Medicaid Services (CMS) has included its ...

Please provide your email address to receive an email when new articles are posted on . An AI-powered device to identify low left ventricular ejection fraction in patients at risk for HF gained 510(k) ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leading AI-driven health technology and nference portfolio company working in collaboration with Mayo Clinic, today announced U.S. Food and Drug ...

Heart failure (HF) substantially impacts the health and financial security of an increasing proportion of the US population. It worsens debility and quality of life and may lead to hospitalization and ...

Using an AI-powered electrocardiogram to diagnose low ejection fraction produced a cost-effectiveness ratio of $27,858 per quality-adjusted life year, according to a study published Oct. 25 in Mayo ...

Credit: Eko Health. The FDA clearance was based on data from a prospective clinical study of 3456 patients. The Food and Drug Administration (FDA) has cleared the Eko Low Ejection Fraction Tool (ELEFT ...

Artificial intelligence can improve diagnosis and treatment for patients, but first the AI-enabled clinical tools have to be easily available and used. New research from Mayo Clinic finds that ...

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of ...